Table 4.
Women: Case‐control study
| Serum creatinine ≤1.02 mg/dL N = 72 | Serum creatinine >1.02 mg/dL N = 130 | |||||
|---|---|---|---|---|---|---|
| Non‐Tx (N = 37) | Tx (N = 35) | P (Mann‐Whitney test) | Non‐Tx (N = 64) | Tx (N = 66) | P (Mann‐Whitney test) | |
| CA125 (kU/L) | 11.0 (8.9‐14.3) | 16.8 (11.6‐35.5) | .0012 | 20.7 (12.5‐30.5) | 18.2 (13.7‐28.6) | .4032 |
| HE4 (pmol/L) | 53.7 (45.7‐75.8) | 84.8 (64.0‐112.2) | .000 026 | 239.8 (155.4‐428.5) | 229.7 (160.5‐431.8) | .7321 |
| Serum creatinine (mg/dL) | 0.84 (0.79‐0.91) | 0.84 (0.78‐0.92) | .7739 | 1.80 (1.42‐3.05) | 1.83 (1.40‐3.01) | .8760 |
| Age (y) | 46.0 (34.2‐60.8) | 46.0 (32.0‐62.8) | .8658 | 58.0 (48.5‐66.0) | 58.5 (47.0‐65.0) | .6632 |
HE4, human epididymis protein 4.
Measured and calculated parameters with respect to the upper reference limit for serum creatinine (1.02 mg/dL) in women with transplants (Tx) and women without transplants (non‐Tx). Divide by 0.01131 to convert creatinine from mg/dL to μmol/L. Data are given as median (interquartile range).